[EN] ISOTOPICALLY ENRICHED ARYLSULFONAMIDE CCR3 ANTAGONISTS<br/>[FR] ANTAGONISTES DE CCR3 À BASE D'ARYLSULFONAMIDE ENRICHI EN ISOTOPE
                        
                            
                                申请人:AXIKIN PHARMACEUTICALS INC
                            
                            
                                公开号:WO2011109345A1
                            
                            
                                公开(公告)日:2011-09-09
                            
                            Provided herein are isotopically enriched arylsulfonamides, for example, of Formula (I), that are useful for modulating CCR3 activity, and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a CCR3-mediated disorder, disease, or condition.